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Heterologous expression of antigenic 
peptides in Bacillus subtilis biofilms
Cédric M. Vogt1, Elisabeth M. Schraner1,3, Claudio Aguilar2* and Catherine Eichwald1* 
Abstract 
Background: Numerous strategies have been developed for the display of heterologous proteins in the surface of 
live bacterial carriers, which can be used as vaccines, immune-modulators, cancer therapy or bioremediation. Bacte-
rial biofilms have emerged as an interesting approach for the expression of proteins of interest. Bacillus subtilis is a 
well-described, endospore-forming organism that is able to form biofilms and also used as a probiotic, thus making it 
a suitable candidate for the display of heterologous proteins within the biofilm. Here, we describe the use of TasA, an 
important structural component of the biofilms formed by B. subtilis, as a genetic tool for the display of heterologous 
proteins.
Results: We first engineered the fusion protein TasA-mCherry and showed that was widely deployed within the B. 
subtilis biofilms. A significant enhancement of the expression of TasA-mCherry within the biofilm was obtained when 
depleting both tasA and sinR genes. We subsequently engineered fusion proteins of TasA to antigenic peptides of 
the E. granulosus parasite, paramyosin and tropomyosin. Our results show that the antigens were well expressed 
within the biofilm as denoted by macrostructure complementation and by the detection of the fusion protein in 
both immunoblot and immunohistochemistry. In addition, we show that the recombinant endospores of B. subtilis 
preserve their biophysical and morphological properties.
Conclusions: In this work we provide strong evidence pointing that TasA is a suitable candidate for the display of 
heterologous peptides, such as antigens, cytokines, enzymes or antibodies, in the B. subtilis biofilms. Finally, our data 
portray that the recombinant endospores preserve their morphological and biophysical properties and could be an 
excellent tool to facilitate the transport and the administration.
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Paramyosin, Antigen
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Background
Live bacteria carriers have been used for several years 
to display heterologous proteins in their surface such 
as antigens, cytokines, enzymes or small-immune pro-
teins for different purposes including vaccines, immu-
nomodulators, cancer therapy or bioremediation. Several 
strategies have been described for the expression of het-
erologous proteins in the surface of bacterial carriers, as 
are: (i) the fusion of a target protein to surface proteins 
from gram-positive or gram-negative bacteria [1–4]; (ii) 
expression via the autotransporter adhesion involved in 
diffuse adherence [5]; (iii) using the LPTXG anchoring 
motif to present antigens in the surface of gram-positive 
bacteria [6] or (iv) via outer membrane vesicles as is for 
gram-negative bacteria [7]. Besides the method used to 
display a heterologous protein, it is highly desired that 
the expression of this protein be enhanced at the best 
of its capacities. For example, inducible promoters have 
been implemented that can drive the expression of a 
heterologous protein and, at the same time, amplify the 
expression plasmid carrying the recombinant gene. 
Such promoters need to be activated at the micro-envi-
ronmental conditions encountered by the live bacteria 
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carriers. Conversely, if the heterologous expression needs 
to be halted, like for in vivo antigen expression, the use of 
common antibiotics or the introduction of inducible sui-
cide genes can be used [8, 9].
Biofilms are communities of surface-associated micro-
organisms encased in a self-produced extracellular matrix 
that commonly comprises lipids, proteins that frequently 
exhibit amyloid-like properties, eDNA and exopolysac-
charides. This matrix fulfills a variety of functions for 
the community, from providing structural rigidity and 
protection from the external environment to controlling 
gene regulation and nutrient adsorption. Thus, the gain 
of knowledge about the bacterial communities is making 
the biofilm an attractive tool for the display heterologous 
proteins in their surface. Even if several uncharacter-
ized proteins are present in the Bacillus subtilis biofilm 
matrix, two important structural proteins have been 
described so far: TasA (translocation-dependent antimi-
crobial spore component) and BslA (biofilm surface layer 
protein) [10]. TasA, besides being a major component 
of the extracellular matrix biofilms, forms amyloid-like 
fibers that have two proposed roles: (i) detoxification of 
potential aggregates of this protein in the cytoplasm and 
(ii) to form the protein-scaffold that supports the assem-
bly of the extracellular matrix [11]. The tapA-sipW-tasA 
operon is necessary for the formation of the amyloid fib-
ers, where TasA stands as main component [12]. Unlike 
the wild type, mutants in tasA are unable to form struc-
tured and complex biofilms, developing only in feature-
less and flat colonies when grown under biofilm-inducing 
conditions [13]. TapA (TasA anchoring and assembly 
protein) is an accessory protein that promotes the effi-
cient polymerization of TasA at the cell envelope, con-
tributing to the organization of the growing fibers and 
acting as connector of the fibers to cell envelope [14]. In 
addition, SipW is a signal peptidase required for TapA 
and TasA processing and secretion [13, 15]. Upon star-
vation conditions, B. subtilis has the capacity to form 
endospores, a dormant form of life with the potential to 
disperse until environmental conditions that are propi-
tious for germination are encountered. It is important 
to denote that B. subtilis spores have been proposed 
as probiotics for animal consumption [16, 17] and in 
humans for diarrhea treatment and the eradication of 
H. pylori [18]. Interestingly, it has been observed that in 
a C. elegans gut model, B. subtilis can interact with host 
pathways in the nitric oxide synthesis, leading to exten-
sion of worm lifespan [19, 20]. In the case of recombinant 
B. subtilis spores, they have been proposed as carrier of 
heterologous proteins by direct attachment to surface 
coat proteins (CotB, CotC, CotG, OxdD, SpsC, CotA 
and CotZ) for diverse applications ranging from oral 
vaccines vehicles to bioremediation tools, and including 
biocatalysts, as well as the generation and screening of 
mutagenesis libraries. In addition, a non-recombinant 
approach has been recently developed to adsorb antigens 
and enzymes on the spore surface [21]. Thereby, the well-
known biology and genetics of B. subtilis plus its capacity 
to form both biofilms and endospores as well as acting as 
probiotic, make of this gram-positive bacteria a suitable 
candidate for the display of heterologous proteins.
Here, we propose an efficient method for the display 
of heterologous proteins in the surface of B. subtilis bio-
films. In our strategy, we show that the red fluorescent 
protein mCherry and also antigenic peptides from E. 
granulosus parasite, EgTrp and EgA31, can be efficiently 
exposed in the biofilm matrix by direct fusion to the 
C-terminus of TasA. We also demonstrate that the spores 
obtained from our recombinant B. subtilis strains are 
biophysically and morphologically identical to wild type 
spores.
Results and discussion
Bacillus subtilis NCIB3610 is a non-domesticated strain 
employed in many studies of bacterial development for 
its ability to form architecturally complex structures 
called biofilms. This strain is very closely related to the 
widely used (domesticated, non-biofilm forming) labo-
ratory strain B. subtilis 168. Thus far, mutations in sev-
eral genes have been identified in B. subtilis 168 which 
have been shown to contribute to biofilm development 
in B. subtilis NCIB3610 [22–24]. In this study, we aimed 
at the expression of heterologous peptides in B. subtilis 
NCIB3610, taking advantage of its remarkable ability 
to form biofilms. The formation of biofilms is partially 
dependent on the activation of the tapA-sipW-tasA 
operon [10, 25]. This activation can be readily monitored 
within the biofilm by using a transcriptional fusion of the 
promoter of this operon (PtapA-yfp) to a reporter gene 
like the fluorescent protein yfp [26]. Our results were in 
perfect agreement with previous observations regard-
ing the expression of this operon in the biofilm (Fig. 1a). 
Since the expression of the tapA operon leads to the pro-
duction of TasA, one of the proteins crucial for biofilm 
development in B. subtilis [13, 26], we next asked if the 
expression of the operon could be correlated to the pres-
ence of TasA in the biofilm. To do this, we engineered 
a protein fusion between TasA and the red fluorescent 
protein, mCherry. As depicted in Fig. 1b, TasA-mCherry 
displays a massive distribution within the biofilm matrix 
at 72  h of biofilm development, in agreement with its 
suggested role in providing structural support within 
the biofilm matrix [12, 13]. Based on the abundant and 
homogeneous distribution of TasA-mCherry in the bio-
film, we hypothesized that TasA may be an excellent 
candidate for exposing heterologous proteins, such as 
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antigenic peptides, enzymes, immunodulators or even 
small-immune molecules. In order to optimize the best 
conditions of expression of a TasA fusion protein, we 
first monitored the abundance of TasA-mCherry, engi-
neered as a tapA-sipW-tasA-mCherry operon in differ-
ent genetic backgrounds. We compared the expression of 
this operon in both the B. subtilis tasA mutant and in a 
double mutant for tasA and sinR (tasA/sinR) strains, to 
the expression of the operon in wild type B. subtilis. The 
mutant tasA has been already described to only form fea-
tureless colonies [26, 27]. Thus, when expressing TasA-
mCherry in the absence of endogenous TasA, we can 
observe a recovery of the biofilm macrostructure archi-
tecture (Fig. 2a, middle row). On the other hand, SinR is 
a repressor of the eps and tapA-sipw-tasA operons whose 
function is antagonized by SinI [13, 28]. In addition, SinR 
is only active in a biofilm in cell subpopulations that 
express tasA-sipW-tapA and eps operons [26, 29]. Thus, 
a mutant in sinR develops biofilms with an exacerbated 
architecture rich in wrinkles and able to retain water, par-
tially due to an overexpression of the eps and tapA-sipw-
tasA operons (Fig. 2a, left panel). On contrast, the double 
mutant tasA/sinR develops in a biofilm with a less com-
plex architecture, as depicted in Fig. 2a (lower row), with 
an overall flat architecture, smooth edges and no evident 
macrostructures. These results are in further agreement 
with the role of TasA as a structural matrix protein. We 
then expressed the tapA-sipW-tasA-mCherry operon 
in both the tasA and the tasA/sinR strains. Our results 
indicate that the expression of the fusion protein TasA-
mCherry was enough to at least partially reconstitute the 
biofilm architecture in both tasA and tasA/sinR mutant 
strains (Fig.  2a, middle and lower rows). An immunob-
lotting of biofilm extracts expressing TasA-mCherry in 
tasA and tasA/sinR strains (Fig. 2b, lanes 3 and 4) exhibit 
a band with an apparent molecular weight of 50 kDa that 
was detected with either anti-TasA or anti-dsRed2 and 
that corresponds to the predicted molecular weight for 
the fusion TasA-mCherry. Similar results were obtained 
for the reconstitution of biofilms as well as for the expres-
sion of TasA-mCherry in pellicles (Additional file 1: Fig-
ure S1a, c). All together, these results indicate that TasA 
can be in fact expressed as a fusion protein within the 
biofilm and that, importantly, the “cargo” did not signifi-
cantly alter the functionality of TasA fused to it, in this 
case mCherry. Based on these observations we were 
encouraged to further characterize different physiologi-
cal and anatomical aspects of B. subtilis when expressing 
TasA as a fusion protein. 
We next identified the best strain for the heterologous 
expression of a peptide fused to the C-terminus of TasA. 
For this purpose, we quantified the red fluorescence 
emitted by the TasA-mCherry protein, monitoring the 
development of biofilms formed by either the wild type, 
tasA and tasA/sinR strains expressing the tapA-sipW-
tasA-mCherry operon at 24, 48 and 72  h (Fig.  2c). Our 
data showed a significant increase in fluorescence in bio-
films formed by the tasA or the tasA/sinR strains over 
the wild type strain when expressing tasA-sipW-tasA-
mCherry operon at all measured times of biofilm devel-
opment. We also observed that, in contrast to tasA strain, 
the tasA/sinR strain displays a persistent and strongest 
fluorescence signal up to 72  h. Based on these results, 
we conclude that the B. subtilis tasA/sinR strain allows 
for the best conditions for expression of a heterologous 
protein.
Upon harsh conditions B. subtilis has the ability to 
form endospores, which are highly resistant to environ-
mental offences [30] and are able to provide protection 
to the encapsidated bacterial genome until the propitious 
conditions for germination are encountered. Since the 
heterologous peptide is encoded in the genome of B. sub-
tilis, it was then reasoned that the endospores could be 
used as delivery agents of the fusion protein. For exam-
ple, if orally administrated, the endospores can bypass 
the acidic stomach barrier and may later germinate in 
the gut, only then expressing the fusion protein of inter-
est. This strategy would at least partially circumvent the 
problems encountered when spore-coat proteins carried 
an antigenic peptide, which could be severely damage 
the integrity of the peptide [31]. By using high-resolution 
electron microscopy, we compared the ultrastructure of 
the endospores formed by the wild type, tasA, sinR and 
tasA/sinR strains (Additional file  2: Fig. S2). We could 
not detect significant structural differences in these 
endospores, indicating that the lack of TasA or SinR 
did not affected the integrity of either the spore coat or 
the peptidoglycan cortex. Also, we then compared the 
Fig. 1 Spatial distribution of TasA within the biofilm. Vertical thin 
sections of biofilms harboring a yfp reporter fusion to PtapA (a) or 
a TasA-mCherry fusion protein (b). Biofilms were frozen at 72 h of 
development prior to cryosectioning and fixation. Images represent 
partial colonies, the edge is shown at the left and the agar surface is 
at the bottom. Transmitted light images were overlaid with fluores-
cence images that were false-colored for each reporter. Bar 50 µm
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sporulation efficiency in biofilms formed by the different 
strains expressing TasA-Cherry (Fig.  2d). As expected, 
wild type and tasA/TasA-mCherry strains show compa-
rable sporulation abilities [26]. On contrast, we observed 
a reduction in the sporulation ability of the sinR and 
tasA/sinR/TasA-mCherry strains. These data were in 
agreement with previous observations from Veening 
et al. [32], explained by a premature activation of the uni-
directional gene cascade of feed-forward loops governing 
spore formation [33]. This reduction in the spores num-
ber observed between wild type and tasA/sinR/TasA-
mCherry, however, was not detected when liquid cultures 
[34] were used instead of biofilms for spore preparation 
(Additional file  3: Fig. S3). Our results indicate that the 
best genetic background for the expression of heterolo-
gous peptides in biofilm of B. subtilis, when in frame with 
the 3′ end of the tapA-sipW-tasA operon, is the tasA/
sinR strain.
To simplify our expression system in biofilms, we 
engineered a non-domesticated B. subtilis NCBI 3610 
strain by double deletion of tasA and sinR genes through 
replacement with a unique antibiotic gene resistance 
(tasA/sinR::kmR, Table  1). As expected, no TasA was 
detected when tested a biofilm extract for the new tasA/
sinR strain (Fig.  3a) by specific anti-TasA immunoblot-
ting. Also, the biofilm colony architecture for the new 
tasA/sinR (Fig.  3c, first row) strain resulted similar to 
the above tasA/sinR with two antibiotic resistance genes 
(Fig.  2a, lower row). Thus, henceforth we will refer to 
the tasA/sinR::kmR strain as the preferred genetic back-
ground for heterologous expression.
As a proof of principle, we tested a series of in-frame 
fusions of Echinococcus granulosus antigenic peptides to 
the C-terminus of TasA. As depicted in the schematic 
representation from Fig. 3b, we selected peptidic regions 
from tropomyosin (EgTrp) and paramyosin (EgA31) 
Fig. 2 a Top view of biofilm architecture from wild type, tasA and tasA/sinR strains with negative (left panels) and positive expression of TasA-
mCherry (right panels) after 72 h of incubation. A magnification of the edges of the colony is presented at the right of each the whole colony 
top view picture. Scale bar is 1 cm. b Immunoblotting of biofilm extracts from wild type (lane 1), sinR (lane 2), tasA::TasA-mcherry (lane 3) and 
tasA/sinR::TasA-mCherry (lane 4) strains; TasA and TasA-mCherry were detected using specific anti-TasA (upper panel) and anti-dsRed2 (lower panel) 
antibodies. The red arrows indicate the position of TasA and TasA-mCherry. The red bracket indicates an anti-TasA reactive band with a lower molecu-
lar weight of TasA, presumably TasA degradation. The molecular weights (kDa) of the proteins are indicated. c Red fluorescence quantification of 
24, 48 and 72 h biofilms. Data is presented as the mean ± SEM of four independent experiments. Asterisks denote significant differences in TasA-
mCherry red fluorescence between tasA and tasA/sinR strains expressing TasA-mCherry (t test, **p < 0.001, n ≥ 4). d Viable spore counts comparing 
sinR, tasA::TasA-mCherry and tasA/sinR::TasA-mCherry to wild type percent of spores in biofilms. Error bars indicate SEM (t-test, *p < 0.05, n = 4)
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from E. granulosus that were previously described for 
their antigenic properties [35, 36]. For this purpose, we 
engineered four B. subtilis strains in a tasA/sinR back-
ground expressing TasA-(102-207)EgTrp, TasA-(102-
278)EgTrp, TasA-(170-369)EgA31 or TasA-(370-583)
EgA31. All these newly engineered strains were able to 
restore the deficient biofilm structure of the tasA/sinR 
strain in semi-solid (Fig.  3c, middle and lower rows) or 
liquid MSgg media (Fig. S1b). The TasA-EgTrp fusion 
proteins were detected in 72 h biofilm extracts by immu-
noblot, using specific anti-TasA and anti-EgTrp antibod-
ies. As depicted in Fig. 3, it was possible to unmistakably 
distinguish the bands that corresponded to the predicted 
molecular weights of 40  kDa for TasA-(102-207)EgTrp 
(Fig.  3d, lanes 3 and 7) and 50  kDa for TasA-(102-278)
EgTrp (Fig. 3d, lanes 4 and 8) fusion proteins. Similarly, 
extracts of biofilms expressing TasA-(170-369)EgA31 
(Fig. 3e, lane 3) and TasA-(370-583)EgA31 (Fig. 3e, lane 
6) showed a band of 43 and 46 kDa (Fig. 3e, upper pan-
els), when using the anti-TasA antibody. We could detect 
only a weak signal for TasA-(170-369)EgA31, suggesting 
low expression levels. This effect was even more dra-
matic when using the anti-EgA31 antibody, where the 
fusion protein was undetectable under the conditions 
used in this assay. It is common to obtain small amounts 
of degradation when engineering and expressing fusion 
proteins. In this particular case, in fact, we were able to 
detect degradation from TasA-EgTrp and TasA-EgA31 
fusion with anti-TasA antibodies but not with the specific 
anti-EgTrp and anti-EgA31, suggesting that the N-termi-
nus of TasA is slightly unstable.
We then examined the localization of the TasA fusion 
proteins within the biofilm by performing anti-TasA 
immunohistochemistry of 72  h biofilm sections. As 
expected (Fig. 4, upper row), TasA from wild type strain 
was distributed in the whole biofilm, while the tasA/sinR 
strain was negative for anti-TasA. The results obtained 
from biofilms expressing TasA fused to E. granulosus 
peptides (Fig.  4, middle and lower rows), exhibited the 
fusion protein from all the inspected sections in the 
biofilm matrix. Despite a relative uniform distribution 
of TasA was observed in the wild type strain, the TasA 
fused to E. granulosus peptides in a tas/sinR background 
showed an evident patchy distribution. This observation 
is consistent with the differences found in the reconsti-
tution of the macro-structural architecture of the bio-
film (Fig. 3) when comparing wild type strain to the ones 
expressing the TasA fusions. It is plausible that the ter-
tiary structure from the peptides fused to TasA could 
influence the secretion of TasA to the extracellular matrix 
or alternatively, that the expression of TasA fused to pep-
tides could alter the balance of the B. subtilis subpopula-
tions within the biofilm.
We next investigated whether the recombinant spores 
carrying the heterologous tapA-sipW-tasA-E. granulo-
sus peptide operon has the same biophysical features as 
the wild type spores, testing for their capacity to endure 
in harsh conditions as high temperature, acidic envi-
ronment and also, shelf-life viability. Upon all these 
conditions (Fig.  5a–c) the recombinant spores were 
not significantly different from the wild type. Moreo-
ver, when examining the ultrastructure of the spores by 
high-definition electron microscopy (Fig.  5d), the spore 
coats and the spore cortex peptidoglycan showed identi-
cal structures in all the inspected spores. Taken together, 
these results provide strong evidence showing that the 
recombinant spores have indistinguishable biophysical 
and morphological properties than the wild type spores, 
Table 1 Bacillus subtilis strains used in this study
Strain Genotype Reference/source
168 Wild type domesticated Kolter Lab., Harvard Medical School
NCIB3610 Wild type undomesticated Kolter Lab., Harvard Medical School
PtapA-yfp (CA018) amyE::PtapA-yfp; Spc
R Vlamakis et al. [26]
tasA (CA017) tasA::KmR Vlamakis et al. [26]
sinR (DS92) sinR::SpcR Kearns et al. [46]
tasA/sinR tasA::KmR; sinR::SpcR This study
TasA-mCherry(CA113) amyE::yqxM-sipW-tasA-mCherry; CmR This study
tasA/TasA-mCherry tasA::KmR; AmyE::yqxM-sipW-tasA-mCherry; CmR This study
tasA/sinR/TasA-mCherry tasA::KmR; sinR::SpcR; amyE::yqxM-sipW-tasA-mCherry; CmR This study
tasA/sinR tasA-sinR::KmR This study
tasA/sinR/TasA-(102-207)EgTrp tasA-sinR::KmR; amyE::yqxM-sipW-tasA-(102-207)EgTrp; SpcR This study
tasA/sinR/TasA-(102-278)EgTrp tasA-sinR::KmR; amyE::yqxM-sipW-tasA-(102-278)EgTrp; SpcR This study
tasA/sinR/TasA-(170-369)EgA31 tasA-sinR::KmR; amyE::yqxM-sipW-tasA-(170-369)EgA31; SpcR This study
tasA/sinR/TasA-(370-583)EgA31 tasA-sinR::KmR; amyE::yqxM-sipW-tasA-(370-583)EgA31; SpcR This study
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suggesting similar resistance to harsh environments, pro-
tection of the genetic material and germination when 
conditions are appropriate.
Conclusions
In this work, we provide strong evidence showing that 
TasA, an important matrix protein for biofilm forma-
tion in B. subtilis, can be used for the display of pro-
teins of interest within the biofilm. Such expression was 
demonstrated using proteins from diverse origins, as are 
the red fluorescent protein mCherry and the antigenic 
peptides from E. granulosus parasite, Egtrp and EgA31. 
By deleting the tasA and sinR genes in a non-domes-
ticated B. subtilis NCBI3610 strain, we were able to 
enhance the expression of the fusion proteins. We show 
that our methodology can be used to effectively express 
the heterologous proteins within the biofilm. This was 
demonstrated by the reestablishment of macrostructures 
Fig. 3 a Immunoblotting of biofilm extract at 72 h for wild type, tasA, sinR and tasA/sinR (single antibiotic selection) strain for the detection of TasA 
using an anti-TasA antibody. b Schematic representation of tapA operon carrying E. granulosus antigenic peptides, EgTrp and EgA31, fused in frame 
at the 3′ end of tasA. tapA, anchoring and assembly protein; sipW, signal peptidase and tasA, major protein matrix. The amino acid region corre-
sponding to each antigenic peptide is indicated. For simplicity of the figures, TasA-(102-207)EgTrp, TasA-(102-278)EgTrp, TasA-(170-369)EgA31 and 
TasA-(370-583)EgA31 are named as (102-207)EgTrp, (102-278)EgTrp, (170-369)EgA31 and (370-583)EgA31, respectively. Diagram not to scale.  
c Top view of biofilm architecture from wild type, tasA/sinR, TasA-(102-207)EgTrp, TasA-(102-278)EgTrp, TasA-(170-369)EgA31 and TasA-(370-583)
EgA31 strains at 72 h. Scale bar is 1 cm. d Immunoblotting of biofilm extract for wild type (lanes 1 and 5), tasA/sinR (lanes 2 and 6), TasA-(102-207) 
EgTrp (lanes 3 and 7) and TasA-(102-279)EgTrp (lanes 4 and 8) strains detected with anti-TasA (left panel) and anti-EgTrp (right panel) antibodies. The 
white arrowhead indicates the position of the TasA-EgTrp antigenic peptides and the red arrow indicates the position of TasA. e Immunoblotting of 
biofilm extracts for wild type (lanes 1 and 4), tasA/sinR (lanes 2 and 5), TasA-(170-369)EgA31 (lane 3) and TasA-(370-583)EgA31 (lane 6) strains detected 
with anti-TasA (upper panel) and anti-EgA31 (lower panel) antibodies. The white arrowhead indicates the position of the TasA-EgA31 antigenic pep-
tides and the red arrow indicates the position of TasA. The protein molecular weights marker (kDa) is indicated
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in an architecture-deficient biofilm background, the 
detection of the fusion proteins in biofilm extracts by 
immunoblot and their localization in biofilm histologi-
cal cuts. Finally, we portrayed that the preserved charac-
teristic of the recombinant spores, due their capacity to 
protect the integrated recombinant tapA-sipW-tasA-gene 
peptide operon, could provide an excellent tool to facili-
tate the transport and desired location for a biofilm to 
display a heterologous protein of interest.
Methods
B. subtilis strains, media and culture conditions
A list with the B. subtilis strains used in this study is 
showed in Table 1. For routine growth and spore quan-
tification, cells were propagated on Luria–Bertani (LB) 
medium. For biofilm assays, cells were scraped from 
overnight growth on LB-agar plates, resuspended in LB 
liquid medium to an OD600  of 1, and then 2  μL of this 
suspension were spotted on MSgg solid medium or in 
2.5 mL of MSgg medium in 22 mm2-well plates [23]. Bio-
films were incubated at 30 °C. The final concentration of 
antibiotics used for the B. subtilis strains were the follow-
ing: spectinomycin (Spc) (100  µg/mL), kanamycin (Km) 
(10 µg/mL) and chloramphenicol (Cm) (5 µg/mL).
Antibodies and reagents
Rabbit polyclonal anti-TasA was a gift from Dr. R. Losick 
(Harvard University, Cambridge, USA). Mouse poly-
clonal anti-EgTrp and mouse polyclonal anti-EgA31 were 
a gift from Dr. M-F. Pétavy (Université Claude Bernard 
Lyon 1, Lyon, France). Rabbit anti-mouse F (ab’)2 frag-
ments Alexa 594 was obtained from Molecular Probes, 
Invitrogen, USA. Goat polyclonal anti-mouse IgG (Fab)’-
peroxidase and goat polyclonal anti-rabbit Ig-peroxidase 
were obtained from Sigma-Aldrich.
Plasmid constructions
The plasmid pDG-TasA-mCherry was obtained by diges-
tion of pBS-TapAop-mCherry with BamHI restriction 
enzyme to obtain TapAop-mCherry and ligated in the 
corresponding sites of pDG1662 [37]. pBS-TapAop-
mCherry was obtained by PCR amplification of mCherry 
Fig. 4 Detection of TasA fusion protein in biofilms by immunohistochemistry. Biofilms were grown for 72 h and then were formalin-fixed, paraffin-
embedded and treated for immunohistochemistry. Images correspond to partial section of the colonies. TasA and TasA fused to E. granulosus anti-
genic peptides for EgTrp and EgA31 were detected using a specific anti-TasA antibody followed by a secondary antibody conjugated to Alexa-594 
(red). Transmitted light images were overlaid with fluorescence images. The agar surface is at the bottom of the each image. Scale bar is 50 µm
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from pRSET-mCherry [38] using specific primers to 
insert XbaI and BamHI/SacI restriction sites respectively 
and, subsequently, ligated in pBS-TapAop between XbaI 
and SacI restriction sites. The plasmid pBS-TapAop was 
obtained by PCR amplification of the tapA-sipW-tasA 
operon from genomic DNA of B. subtilis NCBI3610 
using specific primers to insert BamHI and XbaI restric-
tion sites. The fragment was ligated XbaI and BamHI in 
pBluescript II KS(+)(Stratagene).
The plasmids pDG-TasA-(102–207)EgTrp, pDG-
TasA-(102–278)EgTrp, pDG-TasA-(170–369)EgA31 and 
pDG-TasA-(370–583)EgA31 were obtained by diges-
tion of the plasmids pBS-TapAop-(102–207)EgTrp, pBS-
TapAop-(102–278)EgTrp, pBS-TapAop-(170–369)EgA31 
and pBS-TapAop-(370–583) with XhoI and BamHI restric-
tion enzymes to obtain the fragments TapAop-(102–207)
EgTrp, TapAop-(102–278)EgTrp, TapAop-(170–369)
EgA31 and TapAop-(370–583)EgA31, respectively. The 
fragments were then ligated into pDG1730 [37] between 
XhoI and BamHI restriction sites. The plasmids pBS-
TapAop-(102–207)EgTrp, pBS-TapAop-(102–278)EgTrp, 
pBS-TapAop-(170–369)EgA31 and pBS-TapAop-(370–583) 
were obtained by PCR amplification of EgTrpA and EgA31 
fragments from the constructs pQIA-EgTrp and pQIA-
EgA31 (gently provided by Dr. Adriana Esteves, Univer-
sidad de la República, Montevideo, Uruguay) [39, 40] 
using specific primers containing flanking NotI, BamHI 
and Smal restriction sites (Table  2), followed by ligation 
between NotI and SmaI in pBS-TasAop(SSSN). The plas-
mid pBS-TasAop(SSSN) was obtained by PCR amplification 
of tapA-sipW-tasA operon fragment from pBS-TapAop-
mCherry using specific primers containing XhoI and NotI 
Fig. 5 Wild type and recombinant spores display equal performances. Spores were tested under different conditions as: a heat resistance, b acidic 
medium and c shelf-life storage. Data represent the mean ± SEM from three independent experiments (t-test, not significant, p value >0.05). Error 
bars indicate SEM. d Transmission electron microscopy of wild type, tasA/sinR, TasA-(102-207)Egtrp, TasA-(102-278)EgTrp, TasA-(170-369)EgA31 and 
TasA-(370-583)EgA31 spore strains. Spores were frozen with liquid nitrogen, fixed with glutaraldehyde, counterstained and photographed. Black 
arrowhead, spore coats; white arrowhead, spore cortex peptidoglycan; star, spore protoplast. Scale bars are 50 and 100 nm, as indicated
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restricton sites, followed by ligation between XhoI and NotI 
in pBS(SSSN). The plasmid pBS-MCS(SSSN) was obtained 
by ligation of the annealed oligonucleotides (5′-ATGC-
CTCGAGGGATCCTCAGAGTTAAATGGTATTGCT-3′ 
and 5′-GCATGCGGC CGCATTTTTATCCTCGC-
TATGCGC-3′) between SalI and NotI restriction sites in 
pBluescript-KSII(+) (Stratagene). All oligonucleotides were 
obtained from Microsynth AG, Switzerland and described in 
Table 2.
The long-flanking homology PCR (LFH–PCR) tech-
nique was used for creating the deletion mutant tasA-
sinR::KmR  by means of gene replacement, as described 
by Vlamakis et  al. [26]. For this purpose, a joining PCR 
to create tasA-KmR-sinR was prepared from genomic 
DNA from B. subtilis NCIB3610, amplifying tasA with 
FtasAUP (5′-ACAATAAGTCATGGCCGGA-3′) and 
RtasADO (5′-CCTATCACCTCAAATGG TTCGCTG-
GTTCGCTGGTTTAATACGCTGGCCAA-3′) and sinR 
with FsinRUP (5′-CGAGCGCCTACGAGGAATTTG-
TATCGGCTCCCCTTTTATTGAATG-3′) and Rsin-
RDO (5′-TATGCCGGCTATATGCTT-3′). The KmR gene 
was obtained by amplification of genomic DNA from B. 
subtilis tasA (CA017) strain [26] using the primers FKm-
rUP (5′-CAGCGAACCATTTGAGGTGATAGG-3′) 
and RKmrDo (5′-CGATACAAATTCCTCGTAG-
GCGCTCGG-3′). A B. subtilis 168 tasA/sinR::KmR was 
used as donor strain for transferring the mutant allele 
into the B. subtilis  strain NCIB3610 by means of SPP1-
mediated generalized transduction [41].
Transformation of B. subtilis
Bacillus subtilis strain 168 was transformed routinely 
as described by Cutting and Vander Horn [42]. Briefly, 
bacteria were inoculated in 10  mL of LB medium and 
grown overnight at 37 °C with agitation. After centrifu-
gation, the bacterial pellet was resuspended in trans-
formation medium (6  mM K2HPO4, 4  mM KH2PO4, 
10  mM d-glucose, 100  mg/L casamino acids, 1.5  mM 
L-glutamate, 300  mM sodium citrate, 4  mM ferric 
ammonium citrate, 0.3 mM MgSO4, 25 µM tryptophan 
and 25 µM phenylalanine) and let grow to early station-
ary phase (OD600 nm of 1.25). Then, 1 mL of bacteria were 
mixed with 5  µg of plasmid DNA, and the tubes were 
rolled for 40 min at 37  °C. The cells were plated on LB 
agar medium supplemented with antibiotics. The trans-
formants were selected with the appropriate antibiot-
ics for a double crossover recombination at the amyE 
locus [37]. The diverse tapA-sipW-tasA-fusion gene 
operons were then transferred to NCIB3610 by SPP1-
mediated generalized transduction [41]. The positive 
clones were identified by direct PCR of the selected 
colonies using the following specific primers pDG5′-F 
(5′-ATAATTTTAAATGTAAGCGTT-3′) and pTasAop-
R (5′-CTGTAAAAGAAGCAAAAAAAAA-3′).
Quantification of mCherry fluorescence in biofilms
The biofilm fluorescence (photon/sec) and area (mm2) 
were measured at 24, 48, and 72 h post-inoculation, using 
NightOWL LB 983 (Berthold Technologies). Statistical 
analysis was performed with the aid of Microsoft® Excel® 
for Mac 2011, version 14. 6.2.
Preparation of B. subtilis spores
Bacillus subtilis spores were prepared as described by 
Nicholson and Setlow [34]. Briefly, a colony of B. subti-
lis was inoculated in 3 mL LB media supplemented with 
Table 2 Primers used for plasmid construction
The integrated restriction sites are underlined
The start and stop codons are label in bold
Amplified segment Oligonucleotide sequences
tasA-sipW-tasA operon(1) Fwd: 5′- ATGCGGATCCTCAGAGTTAAATGGTATTGCT-3′
Rev: 5′-GCATTCTAGAATTTTTATCCTCGCTATGCGC
tasA-sipW-tasA operon(2) Fwd.: 5′-ATGCCTCGAGGGATCCTCAGAGTTAAATGGTATTGCT-3′
Rev.: 5′-GCATGCGGCCGCATTTTTATCCTCGCTATGCGC-3′
mCherry Fwd.: 5′-GATCTCTAGAATGGTGAGCAAGGGCGAGGAG-3′
Rev.: 5′-GATCGAGCTCGGATCCTTACTTGTACAGCTCGTCCAT-3′
(102-207)EgTrp Fwd.: 5′ ATGCGCGGCCGCCGAAACATCTACTAAGCTTGAC-3′
Rev.: 5′ GATCCCCCGGGGGATCCTTACTCTTGCTCGGAGACTTCGAG-3′
(102-278)EgTrp Fwd.: 5′ ATGCGCGGCCGCCGAAACATCTACTAAGCTTGAC-3′
Rev.: 5′ GATCCCCGGGGGATCCTCAGAAGGAAGTGAGCTCCGC-3′
(170-369)EgA31 Fwd.: 5′ ATGCGCGGCCGCCGCAGCT5GAAAAACAAGCCATG-3′
Rev.: 5′ GATCCCCGGGGGATCCTCACCTTGTTTCAAGCATTTCAAT-3′
(370-583)EgA31 Fwd.: 5′ ATGCGCGGCCGCCGCTGAGACTAAAGAAATTAAT-3′
Rev.: 5′ GATCCCCGGGGGATCCTCAATCTCTTTCGAGCTGTTTGAT-3′
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antibiotics and incubated at 37  °C for 18  h in a hori-
zontal shaker at 180  rpm. The inoculum was expanded 
in 500 mL LB media in a 2 L Erlenmeyer flask and then 
grown for 12  h at 37  °C in a shaker at 180  rpm. After-
wards, 50  mL of the culture were diluted in 500  mL of 
DSM (8  g/L bacto nutrient broth, 13.4  mM KCl, 2  mM 
MgSO4, 1 mM Ca(NO3)2, 10 µM MnCl2 and 1 µM FeSO4) 
contained in a 2  L Erlenmeyer Flask and incubated for 
72  h at 37  °C in a shaker at 180  rpm. The spores were 
harvested and centrifugated at 14,000×g, for 10 min and 
4 °C, and the pellet heated for 30 min at 80 °C. The pel-
let was subsequently washed with ten volumes of the fol-
lowing solutions: a) 1 M KCl and 0.5 M NaCl; b) 50 mM 
TrisCl pH 7.2 and lysozyme [50  µg/mL], incubated for 
60 min at 37 °C; c) 1 M NaCl and d) twice with ten vol-
umes of deionized water. After each wash, the spores 
were centrifugated at 14,000×g, for 10  min and 4  °C. 
Finally, the pellet was resuspended in deionized water 
and stored at −80  °C for further use. The spore quanti-
fication was determined as described by Vlamakis et  al. 
[26].
Quantification of spores in biofilm
The ability of recombinant B. subtilis to sporulate in a 
biofilm was determined essentially as described by Vlam-
akis et  al. [26]. Briefly, B. subtilis cultured in LB media 
were diluted to OD600 nm of 1 and 10 µL of the suspension 
were inoculated, in duplicate, over 2.5 mL of MSgg media 
in 12-well culture plates. The plates were incubated at 
room temperature with no agitation. Samples of cells 
were taken after 48  h and subjected to mild sonication 
conditions (10  s at 14 kHz) to obtain intact single cells. 
The optical density of each preparation was normalized 
to OD600 nm of 1 after sonication. To kill vegetative cells, 
the normalized preparations were incubated for 20  min 
at 80  °C. To determine viable spore counts, serial dilu-
tions were plated from the normalized preparation after 
the 80 °C incubation.
Immunoblotting
Biofilms in MSgg agar were harvested at 72 h in 500 µL 
of deionized water followed by homogenization by soni-
cation. Samples were normalized to OD600 n of 1. Then, 
20  µL of the normalized sample was mixed with 5  µL 
sample buffer 4× (8 % SDS, 40 % Glycerol, 200 mM Tris 
pH 6.8, 4 % 2-mercaptoethanol, 0.4 % Bromophenol blue) 
and heated for 5 min at 95 °C. Samples were further pro-
cessed as described by Eichwald et al. [43].
Biofilm imaging
Whole colonies were photographed at low magnification 
(0.8×) using a Wild Heerbrugg M5A stereomicroscope 
equipped with a 1.25 × S objective lens, a Leica DFC420 
digital camera, and a computer interface. Data were cap-
tured using LAS V4 (Leica). Pictures were processed 
using ImageJ, version: 2.0.0-rc-44/1.50e software (Crea-
tive Commons license).
Stability of B. subtilis recombinant spores
For each experiment, B. subtilis spores were diluted in 
deionized water and identical aliquots were prepared in 
screw lid tubes. For shelf life stability, spores were stored 
for the indicated times in dark at room temperature. For 
temperatures resistance, the samples were heated for 
30  min at the indicated temperatures. For resistance to 
acidic environment, the spores were centrifugated for 
5  min at 10,000×g, the pellet resuspended in 500  µL of 
a solution at different pHs and incubated for 2 h at 37 °C. 
The number of spores was determined as CFU/mL as 
described by Vlamakis et al. [26]. Experiments were per-
formed in triplicate.
Electron microscopy
A 3  µL aliquot of freshly prepared spores was placed 
on small pieces (2  ×  3  mm) of 4  % trypticase soy 
agar mounted on cigarette paper and slammed on a 
highly polished copper block cooled by liquid nitro-
gen in a freezing device (KF 80, Reichert-Jung, Aus-
tria). Then, the samples were transferred to a freeze 
substitution unit (FS 7500, Boeckler Instruments, 
Tucson, AZ, USA) precooled at −88  °C for substitu-
tion with acetone and subsequently, fixed with 0.25 % 
glutaraldehyde and 0.5 % osmium tetroxide rising the 
temperatures gradually to  +2  °C [44], keeping the 
temperature at −88  °C for up to 2  days. Then, the 
samples were embedded in epon followed by polym-
erization at 60 °C for 2.5 days. Ultrathin Section (70–
80  nm) were cut and stained with uranyl-acetate and 
lead-citrate before analysis in a transmission electron 
microscope (CM12, Philips, Eindhoven, The Nether-
lands) equipped with a CCD camera (Ultrascan 1000, 
Gatan, Pleasanton, CA, USA) at an acceleration volt-
age of 100  kV. Data were analyzed with ImageJ, ver-
sion: 2.0.0-rc-44/1.50e software (Creative Commons 
license).
Immmunohistochemistry of biofilms
A 72 h post-inoculated biofilm, grown in MSgg medium 
fortified with 1.5  % agar, was harvested, formalin-fixed 
and paraffin-embedded [45]. Semi-thin Section (2–3 µm) 
were placed in gelatin pre-coated glass-slides, deparafi-
nizzed by immersion in xylene and rehydrated by immer-
sion in decreasing ethanol gradient (95, 70 and 50 %). The 
slides were immersed in phosphate buffer saline solu-
tion (PBS)(10 mM H3PO4, 137 mM NaCl, 2.7 mM KCl) 
followed by blocking in a 5  % BSA in PBS in a humid 
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chamber. The primary antibody (rabbit polyclonal anti-
tasA antibody, dilution 1:1000) was incubated for 90 min 
at room temperature in a humid chamber, washed twice 
for 3 min in 0.025 % Triton X-100 in PBS and then fol-
lowed by two washes of 3  min in PBS. The secondary 
antibody (anti-rabbit conjugated to Alexa 488, dilution 
1:500) was incubated for 60  min at room temperature 
in a humid chamber. Then, slides were covered with a 
glass coverslip using Prolong Diamond mounting media 
(Molecular Probes). Images were acquired using a fluo-
rescent microscope (Leica DMI 6000B) equipped with an 
HCX/PL/Fluotar 20X objective. All images were acquired 
with the same exposure time and processed using ImageJ, 
version: 2.0.0-rc-44/1.50e software (Creative Commons 
license).
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